5PSQ-075 Fingolimod-associated lymphopaenia in multiple sclerosis patients

BACKGROUND: Fingolimod changes lymphocyte count. PURPOSE: To evaluate changes in lymphocyte count and infection incidence in patients with multiple sclerosis (MS) receiving fingolimod. MATERIAL AND METHODS: Retrospective study that included all fingolimod-treated patients in a tertiary hospital. Pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Navarro, M, Betancor, T, Diaz, P, Calzado, G, Ramos, E, Suárez, M, Vera, M, Plasencia, I, Ferrer, A, Merino, J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 5: Patient safety and quality assurance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535408/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.429
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados